Authors: Weiser, T Wienrich, M Brenner, M Kubiak, R Weckesser, G Palluk, R

Citation: T. Weiser et al., The AMPA receptor/Na+ channel blocker BIIR 561 CL is protective in a modelof global cerebral ischaemia, EUR J PHARM, 421(3), 2001, pp. 165-170

Authors: Wienrich, M Brenner, M Loscher, W Palluk, R Pieper, M Potschka, H Weiser, T

Citation: M. Wienrich et al., In vivo pharmacology of BIIR 561 CL, a novel combined antagonist of AMPA receptors and voltage-dependent Na+ channels, BR J PHARM, 133(6), 2001, pp. 789-796

Authors: Weiser, T Iizuka, M Nishimura, S Akiba, I Barsoumian, E Zhou, M Steinhauser, C Brenner, M Palluk, R Wienrich, M

Citation: T. Weiser et al., Characterization of the anticonvulsant and neuroprotectant BIIR 561 CL in vitro: effects on native and recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, N-S ARCH PH, 362(4-5), 2000, pp. 419-426

Authors: Weiser, T Brenner, M Palluk, R Bechtel, WD Ceci, A Brambilla, A Ensinger, HA Sagrada, A Wienrich, M

Citation: T. Weiser et al., BIIR 561 CL: A novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties, J PHARM EXP, 289(3), 1999, pp. 1343-1349